^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BL-M02D1

    i
    Company:
    Biokin Pharma
    Drug class:
    Topoisomerase I inhibitor, TROP-2-targeted antibody-drug conjugate
    Related drugs:
    Apply
    A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors (NCT05385692)
    Phase 1
    Sichuan Baili Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    01/31/2024
    Initiation :
    06/01/2022
    Primary completion :
    06/01/2024
    Completion :
    06/01/2024
    TACSTD2
    |
    BL-M02D1